RET and thyroid gland carcinoma: RET/PTC3 (Ret proto-oncogene and Ret-activating protein ELE1) rearrangement is the most frequent genetic alteration in thyroid cancer and most functions of RET are mediated through pathways including ERK, JNK, and PI3K/AKT [100,101,102,103].